IRONWOOD PHARMACEUTICALS, INC. Net Income (Loss) Available to Common Stockholders, Basic
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Net Income (Loss) Available to Common Stockholders, Basic of $51.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was $51.29M, a 117.34% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was $40.77M.
- IRONWOOD PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$2.28M, a 200.89% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was $40.08M, a 999.29% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was $24.02M, a 2629.20% increase from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was $880.00K.
- IRONWOOD PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$1.00B, a 672.50% decline from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was $175.06M, a 66.87% decline from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $51.29M 10-Q · filed 2026-08-06 | $92.06M 10-Q · filed 2026-08-06 | $89.79M derived: sum of 3 quarters · filed 2026-08-06 | $129.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $40.77M 10-Q · filed 2026-05-07 | $38.50M derived: sum of 2 quarters · filed 2026-05-07 | $78.58M derived: sum of 3 quarters · filed 2026-05-07 | $102.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $37.80M derived: sum of 2 quarters · filed 2026-02-26 | $61.40M derived: sum of 3 quarters · filed 2026-08-06 | $24.02M 10-K · filed 2026-02-26 |
| 2025-09-30 | $40.08M 10-Q · filed 2025-11-10 | $63.68M derived: sum of 2 quarters · filed 2026-08-06 | $26.29M 10-Q · filed 2025-11-10 | $28.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $23.60M 10-Q · filed 2026-08-06 | -$13.79M 10-Q · filed 2026-08-06 | -$11.53M derived: sum of 3 quarters · filed 2026-08-06 | -$7.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$37.39M 10-Q · filed 2026-05-07 | -$35.13M derived: sum of 2 quarters · filed 2026-05-07 | -$31.48M derived: sum of 3 quarters · filed 2026-05-07 | -$32.34M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.90M derived: sum of 2 quarters · filed 2026-02-26 | $5.04M derived: sum of 3 quarters · filed 2026-02-26 | $880.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.65M 10-Q · filed 2025-11-10 | $2.79M derived: sum of 2 quarters · filed 2025-11-10 | -$1.38M 10-Q · filed 2025-11-10 | -$2.46M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$860.00K 10-Q · filed 2025-08-11 | -$5.02M 10-Q · filed 2025-08-11 | -$6.11M derived: sum of 3 quarters · filed 2025-08-11 | $9.21M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$4.16M 10-Q · filed 2024-05-09 | -$5.25M derived: sum of 2 quarters · filed 2025-03-31 | $10.07M derived: sum of 3 quarters · filed 2025-03-31 | |
| 2023-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $14.23M derived: sum of 2 quarters · filed 2025-03-31 | -$1.00B 10-K · filed 2025-03-31 | |
| 2023-09-30 | $15.32M 10-Q · filed 2024-11-07 | -$1.00B 10-Q · filed 2024-11-07 | ||
| 2023-03-31 | $45.71M 10-Q · filed 2024-05-09 | $94.58M derived: sum of 2 quarters · filed 2025-03-31 | $144.90M derived: sum of 3 quarters · filed 2025-03-31 | $181.98M derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | $48.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $99.18M derived: sum of 2 quarters · filed 2025-03-31 | $136.26M derived: sum of 3 quarters · filed 2025-03-31 | $175.06M 10-K · filed 2025-03-31 |
| 2022-09-30 | $50.32M 10-Q · filed 2023-11-09 | $87.40M derived: sum of 2 quarters · filed 2023-11-09 | $126.20M 10-Q · filed 2023-11-09 | $167.57M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $37.08M 10-Q · filed 2022-08-04 | $75.88M 10-Q · filed 2022-08-04 | $117.25M derived: sum of 3 quarters · filed 2024-02-16 | $173.10M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $38.80M 10-Q · filed 2023-05-04 | $80.17M derived: sum of 2 quarters · filed 2024-02-16 | $136.02M derived: sum of 3 quarters · filed 2024-02-16 | $527.32M derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $41.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $97.22M derived: sum of 2 quarters · filed 2024-02-16 | $488.52M derived: sum of 3 quarters · filed 2024-02-16 | $528.45M 10-K · filed 2024-02-16 |
| 2021-09-30 | $55.84M 10-Q · filed 2022-11-03 | $447.15M derived: sum of 2 quarters · filed 2022-11-03 | $487.07M 10-Q · filed 2022-11-03 | $530.28M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $391.30M 10-Q · filed 2022-08-04 | $431.23M 10-Q · filed 2022-08-04 | $474.43M derived: sum of 3 quarters · filed 2023-02-16 | $508.86M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $39.93M 10-Q · filed 2022-05-05 | $83.13M derived: sum of 2 quarters · filed 2023-02-16 | $117.55M derived: sum of 3 quarters · filed 2023-02-16 | $142.76M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $43.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $77.63M derived: sum of 2 quarters · filed 2023-02-16 | $102.83M derived: sum of 3 quarters · filed 2023-02-16 | $106.18M 10-K · filed 2023-02-16 |
| 2020-09-30 | $34.42M 10-Q · filed 2021-11-04 | $59.63M derived: sum of 2 quarters · filed 2021-11-04 | $62.97M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $25.20M 10-Q · filed 2021-08-05 | $28.55M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $3.35M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $21.50M 10-K · filed 2022-02-18 | |||
| 2018-12-31 | -$282.37M 10-K · filed 2021-02-17 | |||
| 2017-03-31 | -$52.50M 10-Q · filed 2017-05-08 | -$66.01M derived: sum of 2 quarters · filed 2017-05-08 | -$99.21M derived: sum of 3 quarters · filed 2017-05-08 | -$120.91M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-12-31 | -$13.51M 10-K · filed 2017-02-22 | -$46.71M derived: sum of 2 quarters · filed 2017-02-22 | -$68.41M derived: sum of 3 quarters · filed 2017-02-22 | -$81.71M 10-K · filed 2017-02-22 |
| 2016-09-30 | -$33.20M 10-K · filed 2017-02-22 | -$54.91M derived: sum of 2 quarters · filed 2017-02-22 | -$68.20M 10-Q · filed 2016-11-07 | -$82.24M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-06-30 | -$21.70M 10-K · filed 2017-02-22 | -$35.00M 10-Q · filed 2016-08-08 | -$49.04M derived: sum of 3 quarters · filed 2017-05-08 | -$96.43M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-03-31 | -$13.30M 10-Q · filed 2017-05-08 | -$27.33M derived: sum of 2 quarters · filed 2017-05-08 | -$74.72M derived: sum of 3 quarters · filed 2017-05-08 | -$122.74M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | -$14.04M 10-K · filed 2017-02-22 | -$61.43M derived: sum of 2 quarters · filed 2017-02-22 | -$109.45M derived: sum of 3 quarters · filed 2017-02-22 | -$142.67M 10-K · filed 2017-02-22 |
| 2015-09-30 | -$47.39M 10-K · filed 2017-02-22 | -$95.41M derived: sum of 2 quarters · filed 2017-02-22 | -$128.63M 10-Q · filed 2016-11-07 | -$166.28M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | -$48.02M 10-K · filed 2017-02-22 | -$81.24M 10-Q · filed 2016-08-08 | -$118.89M derived: sum of 3 quarters · filed 2017-02-22 | -$160.88M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | -$33.22M 10-K · filed 2017-02-22 | -$70.87M derived: sum of 2 quarters · filed 2017-02-22 | -$112.86M derived: sum of 3 quarters · filed 2017-02-22 | -$173.21M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | -$37.65M 10-K · filed 2016-02-19 | -$79.64M derived: sum of 2 quarters · filed 2016-02-19 | -$139.99M derived: sum of 3 quarters · filed 2016-02-19 | -$189.62M 10-K · filed 2017-02-22 |
| 2014-09-30 | -$41.99M 10-K · filed 2016-02-19 | -$102.34M derived: sum of 2 quarters · filed 2016-02-19 | -$151.97M 10-Q · filed 2015-11-05 | -$203.96M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | -$60.36M 10-K · filed 2016-02-19 | -$109.98M 10-Q · filed 2015-08-07 | -$161.97M derived: sum of 3 quarters · filed 2016-02-19 | -$223.74M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | -$49.63M 10-K · filed 2016-02-19 | -$101.61M derived: sum of 2 quarters · filed 2016-02-19 | -$163.39M derived: sum of 3 quarters · filed 2016-02-19 | -$228.54M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | -$51.99M 10-K · filed 2015-02-18 | -$113.76M derived: sum of 2 quarters · filed 2015-02-18 | -$178.91M derived: sum of 3 quarters · filed 2015-02-18 | -$272.81M 10-K · filed 2016-02-19 |
| 2013-09-30 | -$61.77M 10-K · filed 2015-02-18 | -$126.92M derived: sum of 2 quarters · filed 2015-02-18 | -$220.83M 10-Q · filed 2014-11-05 | -$264.68M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | -$65.15M 10-K · filed 2015-02-18 | -$159.05M 10-Q · filed 2014-08-05 | -$202.91M derived: sum of 3 quarters · filed 2015-02-18 | -$155.27M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | -$93.90M 10-K · filed 2015-02-18 | -$137.76M derived: sum of 2 quarters · filed 2015-02-18 | -$90.12M derived: sum of 3 quarters · filed 2015-02-18 | -$130.93M derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | -$43.85M 10-K · filed 2014-02-07 | $3.78M derived: sum of 2 quarters · filed 2014-02-07 | -$37.02M derived: sum of 3 quarters · filed 2014-02-07 | -$72.62M 10-K · filed 2015-02-18 |
| 2012-09-30 | $47.63M 10-K · filed 2014-02-07 | $6.83M derived: sum of 2 quarters · filed 2014-02-07 | -$28.77M 10-Q · filed 2013-10-28 | -$35.74M derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-06-30 | -$40.80M 10-K · filed 2014-02-07 | -$76.40M 10-Q · filed 2013-08-08 | -$83.38M derived: sum of 3 quarters · filed 2014-02-07 | -$104.01M derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-03-31 | -$35.60M 10-K · filed 2014-02-07 | -$42.58M derived: sum of 2 quarters · filed 2014-02-07 | -$63.21M derived: sum of 3 quarters · filed 2014-02-07 | -$82.05M derived: sum of 4 quarters · filed 2014-02-07 |
| 2011-12-31 | -$6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | -$27.61M derived: sum of 2 quarters · filed 2014-02-07 | -$46.45M derived: sum of 3 quarters · filed 2014-02-07 | -$64.85M 10-K · filed 2014-02-07 |
| 2011-09-30 | -$20.63M 10-Q · filed 2012-11-06 | -$39.48M derived: sum of 2 quarters · filed 2012-11-06 | -$57.88M 10-Q · filed 2012-11-06 | -$69.53M derived: sum of 4 quarters · filed 2012-11-06 |
| 2011-06-30 | -$18.84M 10-Q · filed 2012-08-07 | -$37.24M 10-Q · filed 2012-08-07 | -$48.90M derived: sum of 3 quarters · filed 2012-08-07 | -$57.17M derived: sum of 4 quarters · filed 2012-08-07 |
| 2011-03-31 | -$18.40M 10-Q · filed 2012-05-10 | -$30.05M derived: sum of 2 quarters · filed 2012-05-10 | -$38.32M derived: sum of 3 quarters · filed 2012-05-10 | -$55.46M derived: sum of 4 quarters · filed 2012-05-10 |
| 2010-12-31 | -$11.65M 10-K · filed 2012-02-29 | -$19.92M derived: sum of 2 quarters · filed 2012-02-29 | -$37.06M derived: sum of 3 quarters · filed 2012-02-29 | -$52.98M 10-K · filed 2013-02-21 |
| 2010-09-30 | -$8.27M 10-K · filed 2012-02-29 | -$25.41M derived: sum of 2 quarters · filed 2012-02-29 | -$41.33M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | -$17.14M 10-K · filed 2012-02-29 | -$33.06M derived: sum of 2 quarters · filed 2012-02-29 | ||
| 2010-03-31 | -$15.92M 10-K · filed 2012-02-29 | |||
| 2009-12-31 | -$71.19M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |